It has been shown that the overexpression of lipid metabolism-related enzymes (e.g., FASN and SREBPs) is correlated with advanced stages of different type of cancers, poor patient survival, and cancer cell proliferation, invasion, and metastasis [75]. Here, FASN is linked to cancer.